CompletedNot Applicable

the Pops-titration Versus the Slow-coagulation Cyclophotocoagulation in Treatment of Refractory Glaucoma

Thailand98 participantsStarted 2013-05

Plain-language summary

* Transcleral cyclophotocoagulation (TSCPC) has long been used as refractory glaucoma management and is very easy to learn and easy to perform. * Recent advances in laser technology; the role of TSCPC is being expanded because it has benefits of noninvasive glaucoma procedure. * The titration (pops), the fixed high-energy, and the fixed-low energy (slow-coagulation) are three energy delivery techniques. * The present study would report on the outcome (efficacy and safety) of the slow-coagulation versus the titration method in treatment of refractory glaucoma with dark iris. * The results would provide reliable evidences to supplement clinical judgment when making a decision in favor of each treatment method for glaucoma patients.

Who can participate

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Refractory glaucoma (Neovascular glaucoma) with * Eyes with no visual potential and very high intraocular pressure (on maximal medical treatment) in which the intraocular pressure will probably cause corneal complications * Eyes with no visual potential and very high intraocular pressure (on maximal medical treatment) in which the intraocular pressure cause eye pain and need pain relief * Eyes with minimal useful vision and intraocular pressure over the target intraocular pressure * Eyes in which trabeculectomy with mitomycin-C and/or drainage implants have a high probability of failure * Eyes in which trabeculectomy with mitomycin-C and/or drainage implants have previously failed * Patient refuses to undergo more aggressive intraocular surgery * Patients whose general medical condition precludes invasive surgery Exclusion Criteria: * The visual acuity in the fellow eye is no light perception * Have previously been treated by the transcleral cyclophotocoagulation * Allergy to anesthetic medication * Can not measure the intraocular pressure by the applanation method

What they're measuring

Success rate

Timeframe: 60 months

Trial details

NCT IDNCT01774227

SponsorPrince of Songkla University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-01